HCN4, sinus bradycardia and atrial fibrillation

Arrhythmia and Electrophysiology Review

Volumn 4, Issue 1, 2015, Pages 9-13

  Di Francesco, Dario ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Arrhythmias; Atrial fibrillation; AV block; Bradycardia; Funny current; HCN4 channels

Indexed keywords

CYCLIC NUCLEOTIDE GATED CHANNEL; CYCLIC NUCLEOTIDE GATED CHANNEL 4; POTASSIUM CHANNEL KCNE2; UNCLASSIFIED DRUG;

ARTICLE; ATRIAL FIBRILLATION; ATRIOVENTRICULAR BLOCK; ATRIOVENTRICULAR CONDUCTION; GENETIC SCREENING; HEART RATE; HUMAN; LOSS OF FUNCTION MUTATION; NONHUMAN; SINUS BRADYCARDIA;

EID: 84978457948     PISSN: 20503369     EISSN: 20503377     Source Type: Journal    
DOI: 10.15420/aer.2015.4.1.9     Document Type: Article

References (70)

1. Brown HF, DiFrancesco D, Noble SJ. How does adrenaline accelerate the heart? Nature 1979;280(5719): 235-6.
2. DiFrancesco D. Pacemaker mechanisms in cardiac tissue. Annu Rev Physiol 1993;55: 455-72.
3. DiFrancesco D, Borer JS. The funny current: Cellular basis for the control of heart rate. Drugs 2007;67 Suppl 2: 15-24.
4. Barbuti A, Baruscotti M, DiFrancesco D. The pacemaker current: From basics to the clinics. J Cardiovasc Electrophysiol 2007;18(3): 342-7.
5. DiFrancesco D. The role of the funny current in pacemaker activity. Circ Res 2010;106(3): 434-46.
6. Liu J, Dobrzynski H, Yanni J, et al. Organisation of the mouse sinoatrial node: Structure and expression of HCN channels. Cardiovasc Res 2007;73(4): 729-38.
7. Mommersteeg MT, Hoogaars WM, Prall OW, et al. Molecular pathway for the localized formation of the sinoatrial node. Circ Res 2007;100(3): 354-62.
8. Wiese C, Grieskamp T, Airik R, et al. Formation of the sinus node head and differentiation of sinus node myocardium are independently regulated by Tbx18 and Tbx3. Circ Res 2009;104(3): 388-97.
9. Brioschi C, Micheloni S, Tellez JO, et al. Distribution of the pacemaker HCN4 channel mRNA and protein in the rabbit sinoatrial node. J Mol Cell Cardiol 2009;47(2): 221-7.
10. Lakatta EG, DiFrancesco D. What keeps us ticking: A funny current, a calcium clock, or both? J Mol Cell Cardiol 2009;47(2): 157-70.
11. DiFrancesco D, Camm JA. Heart rate lowering by specific and selective If current inhibition with ivabradine: A new therapeutic perspective in cardiovascular disease. Drugs 2004;64(16): 1757-65.
12. Bucchi A, Baruscotti M, DiFrancesco D. Current-dependent block of rabbit sino-atrial node I(f) channels by ivabradine. J Gen Physiol 2002;120(1): 1-13.
13. DiFrancesco D. If inhibition: A novel mechanism of action. Eur Heart J 2003;5(suppl G): G19-25.
14. Bucchi A, Tognati A, Milanesi R, et al. Properties of ivabradine-induced block of HCN1 and HCN4 pacemaker channels. J Physiol 2006;572(Pt 2): 335-46.
15. Borer JS, Fox K, Jaillon P, Lerebours G. Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: A randomized, double-blind, multicentered, placebo-controlled trial. Circulation 2003;107(6): 817-23.
16. Camm AJ, Lau CP. Electrophysiological effects of a single intravenous administration of ivabradine (S 16257) in adult patients with normal baseline electrophysiology. Drugs R D 2003;4(2): 83-9.
17. Calò L, Rebecchi M, Sette A, et al. Efficacy of ivabradine administration in patients affected by inappropriate sinus tachycardia. Heart Rhythm 2010;7(9): 1318-23.
18. Kumar S, Vohra J. Ivabradine: Appropriate treatment for inappropriate sinus tachycardia. Heart Rhythm 2010;7(9): 1324-5.
19. Zellerhoff S, Hinterseer M, Felix Krull B, et al. Ivabradine in patients with inappropriate sinus tachycardia. Naunyn Schmiedebergs Arch Pharmacol 2010;382(5-6): 483-6.
20. Weyn T, Stockman D, Degreef Y. The use of ivabradine for inappropriate sinus tachycardia. Acta Cardiol 2011;66(2): 259-62.
21. Femenía F, Baranchuk A, Morillo CA. Inappropriate sinus tachycardia: Current therapeutic options. Cardiol Rev 2012;20(1): 8-14.
22. Rosen MR, Brink PR, Cohen IS, Robinson RB. Genes, stem cells and biological pacemakers. Cardiovasc Res 2004;64(1): 12-23.
23. Rosen MR, Robinson RB, Brink PR, Cohen IS. The road to biological pacing. Nat Rev Cardiol 2011;8(11): 656-66.
24. Baruscotti M, Bottelli G, Milanesi R, et al. HCN-related channelopathies. Pflugers Arch 2010;460(2): 405-15.
25. DiFrancesco D. Funny channel gene mutations associated with arrhythmias. J Physiol 2013;591(Pt 17): 4117-24.
26. Verkerk AO, Wilders R. Pacemaker activity of the human sinoatrial node: Effects of HCN4 mutations on the hyperpolarization-activated current. Europace 2014;16(3): 384-95.
27. Zagotta WN, Olivier NB, Black KD, et al. Structural basis for modulation and agonist specificity of HCN pacemaker channels. Nature 2003;425(6954): 200-5.
28. Decher N, Chen J, Sanguinetti MC. Voltage-dependent gating of hyperpolarization-activated, cyclic nucleotide-gated pacemaker channels: Molecular coupling between the S4-S5 and C-linkers. J Biol Chem 2004;279(14): 13859-65.
29. Milano A, Vermeer AM, Lodder EM, et al. HCN4 mutations in multiple families with bradycardia and left ventricular noncompaction cardiomyopathy. J Am Coll Cardiol 2014;64(8): 745-56.
30. Schweizer PA, Schröter J Greiner S, et al. The symptom complex of familial sinus node dysfunction and myocardial noncompaction is associated with mutations in the HCN4 channel. J Am Coll Cardiol 2014;64(8): 757-67.
31. Bucchi A, Baruscotti M, Robinson RB, DiFrancesco D. Modulation of rate by autonomic agonists in SAN cells involves changes in diastolic depolarization and the pacemaker current. J Mol Cell Cardiol 2007;43(1): 39-48.
32. DiFrancesco D. Considerations on the size of currents required for pacemaking. J Mol Cell Cardiol 2010;48(4): 802-3.
33. Milanesi R, Baruscotti M, Gnecchi-Ruscone T, DiFrancesco D. Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel. N Engl J Med 2006;354(2): 151-7.
34. DiFrancesco D, Ducouret P, Robinson RB. Muscarinic modulation of cardiac rate at low acetylcholine concentrations. Science 1989;243(4891): 669-71.
35. Macri V, Mahida SN, Zhang ML, et al. A novel trafficking-defective HCN4 mutation is associated with early-onset atrial fibrillation. Heart Rhythm 2014;11(6): 1055-62.
36. Zhou J, Ding WG, Makiyama T, et al. A novel HCN4 mutation, G1097W, is associated with atrioventricular block. Circ J 2014;78(4): 938-42.
37. Stieber J, Herrmann S, Feil S, et al. The hyperpolarization-activated channel HCN4 is required for the generation of pacemaker action potentials in the embryonic heart. Proc Natl Acad Sci U S A 2003;100(25): 15235-40.
38. Kokubun S, Nishimura M, Noma A, Irisawa H. Membrane currents in the rabbit atrioventricular node cell. Pflugers Arch 1982;393: 15-22.
39. Liu J, Noble PJ, Xiao G, et al. Role of pacemaking current in cardiac nodes: Insights from a comparative study of sinoatrial node and atrioventricular node. Prog Biophys Mol Biol 2008;96(1-3): 294-304.
40. Chen YC, Pan NH, Cheng CC, et al. Heterogeneous expression of potassium currents and pacemaker currents potentially regulates arrhythmogenesis of pulmonary vein cardiomyocytes. J Cardiovasc Electrophysiol 2009;20(9): 1039-45.
41. Suenari K, Cheng CC, Chen YC, et al. Effects of ivabradine on the pulmonary vein electrical activity and modulation of pacemaker currents and calcium homeostasis. J Cardiovasc Electrophysiol 2012;23(2): 200-6.
42. Haïssaguerre M, Jaïs P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339(10): 659-66.
43. Chen SA, Hsieh MH, Tai CT, et al. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: Electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation 1999;100(18): 1879-86.
44. Yeh YH, Burstein B, Qi XY, et al. Funny current downregulation and sinus node dysfunction associated with atrial tachyarrhythmia: A molecular basis for tachycardia-bradycardia syndrome. Circulation 2009;119(12): 1576-85.
45. Ellinor PT, Lunetta KL, Albert CM, et al. Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet 2012;44(6): 670-5.
46. Tran N, Proenza C, Macri V, et al. A conserved domain in the NH2 terminus important for assembly and functional expression of pacemaker channels. J Biol Chem 2002;277(46): 43588-92.
47. Barbuti A, Scavone A, Mazzocchi N, et al. A caveolin-binding domain in the HCN4 channels mediates functional interaction with caveolin proteins. J Mol Cell Cardiol 2012;53(2): 187-95.
48. Baruscotti M, Bucchi A, Viscomi C, et al. Deep bradycardia and heart block caused by inducible cardiac-specific knockout of the pacemaker channel gene Hcn4. Proc Natl Acad Sci U S A 2011;108(4): 1705-10.
49. Yu H, Wu J, Potapova I, et al. MinK-related peptide 1: A beta subunit for the HCN ion channel subunit family enhances expression and speeds activation. Circ Res 2001;88(12): E84-7.
50. Qu J, Kryukova Y, Potapova IA, et al. MiRP1 modulates HCN2 channel expression and gating in cardiac myocytes. J Biol Chem 2004;279(42): 43497-502.
51. Barbuti A, Gravante B, Riolfo M, et al. Localization of pacemaker channels in lipid rafts regulates channel kinetics. Circ Res 2004;94(10): 1325-31.
52. Barbuti A, Terragni B, Brioschi C, DiFrancesco D. Localization of f-channels to caveolae mediates specific ß2-adrenergic receptor modulation of rate in sinoatrial myocytes. J Mol Cell Cardiol 2007;42(1): 71-8.
53. Barbuti A, Bucchi A, Milanesi R, et al. The "funny" pacemaker current. In: Tripathi ON, Ravens U, Sanguinetti MC (eds). Heart Rate and Rhythm: Molecular Basis, Pharmacological Modulation and Clinical Implications. Heidelberg, Germany: Springer Berlin, 2011;59-81.
54. Abbott GW, Sesti F, Splawski I, et al. MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell 1999;97(2): 175-87.
55. Splawski I, Tristani-Firouzi M, Lehmann MH, et al. Mutations in the hminK gene cause long QT syndrome and suppress IKs function. Nat Genet 1997;17(3): 338-40.
56. Nawathe PA, Kryukova Y, Oren RV, et al. An LQTS6 MiRP1 Mutation Suppresses Pacemaker Current and is Associated with Sinus Bradycardia. J Cardiovasc Electrophysiol 2013;24(9): 1021-7.
57. Cerbai E, Sartiani L, DePaoli P, et al. The properties of the pacemaker current If in human ventricular myocytes are modulated by cardiac disease. J Mol Cell Cardiol 2001;33(3): 441-8.
58. Stillitano F, Lonardo G, Zicha S, et al. Molecular basis of funny current (If) in normal and failing human heart. J Mol Cell Cardiol 2008;45(2): 289-99.
59. Harris BS, Baicu CF, Haghshenas N, et al. Remodeling of the peripheral cardiac conduction system in response to pressure overload. Am J Physiol Heart Circ Physiol 2012;302(8): H1712-25.
60. al-Ani M, Munir SM, White M, et al. Changes in R-R variability before and after endurance training measured by power spectral analysis and by the effect of isometric muscle contraction. Eur J Appl Physiol Occup Physiol 1996;74(5): 397-403.
61. Maron BJ, Pelliccia A. The heart of trained athletes: Cardiac remodeling and the risks of sports, including sudden death. Circulation 2006;114(15): 1633-44.
62. D'Souza A, Bucchi A, Johnsen AB, et al. Exercise training reduces resting heart rate via downregulation of the funny channel HCN4. Nature Comm 2014;5: 3775.
63. Baldesberger S, Bauersfeld U, Candinas R, et al. Sinus node disease and arrhythmias in the long-term follow-up of former professional cyclists. Eur Heart J 2008;29(1): 71-8.
64. O'Keefe JH, Patil HR, Lavie CJ, et al. Potential adverse cardiovascular effects from excessive endurance exercise. Mayo Clin Proc 2012;87(6): 587-95.
65. Schulze-Bahr E, Neu A, Friederich P, et al. Pacemaker channel dysfunction in a patient with sinus node disease. J Clin Invest 2003;111(10): 1537-45.
66. Ueda K, Nakamura K, Hayashi T, et al. Functional characterization of a trafficking-defective HCN4 mutation, D553N, associated with cardiac arrhythmia. J Biol Chem 2004;279(26): 27194-8.
67. Nof E, Luria D, Brass D, et al. Point mutation in the HCN4 cardiac ion channel pore affecting synthesis, trafficking, and functional expression is associated with familial asymptomatic sinus bradycardia. Circulation 2007;116(5): 463-70.
68. Laish-Farkash A, Glikson M, Brass D, et al. A novel mutation in the HCN4 gene causes symptomatic sinus bradycardia in Moroccan Jews. J Cardiovasc Electrophysiol 2010;21(12): 1365-72.
69. Schweizer PA, Duhme N, Thomas D, et al. cAMP sensitivity of HCN pacemaker channels determines basal heart rate but is not critical for autonomic rate control. Circ Arrhithm Electrophysiol 2010;3(5): 542-52.
70. Duhme N, Schweizer PA, Thomas D, et al. Altered HCN4 channel C-linker interaction is associated with familial tachycardia-bradycardia syndrome and atrial fibrillation. Eur Heart J 2013;34(35): 2768-75.